Mrs. Kelly Thornton, PT Physical Therapist - Orthopedic Medicare: Medicare Enrolled Practice Location: 5200 Executive Centre Pkwy Ste 200, Saint Peters, MO 63376 Phone: 636-255-8750 |
Envision Rehab And Wellness Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 7421 Mexico Rd Ste 102, Saint Peters, MO 63376 Phone: 636-757-6543 Fax: 636-639-4337 |
Jill Marie Carroll Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 45 Chaunston Ct, Saint Peters, MO 63376 Phone: 636-294-2224 |
Mr. Eric Dante Bureros Buscato, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 703 Lorillard St, Saint Peters, MO 63376 Phone: 573-931-3567 |
Megan Kovacs, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4200 N Cloverleaf Dr Ste J, Saint Peters, MO 63376 Phone: 636-922-4700 |
News Archive
According to a study conducted at the Department of Pedagogy of the University of Granada, about six out of ten male drug-abusers direct some type of violence against their intimate partners.
Scientists are reporting discovery of a way to help proteins such as the new generation of protein-based drugs - sometimes heralded as tomorrow's potential "miracle cures" - get past the biochemical "Entrance Forbidden" barrier that keeps them from entering cells and doing their work. The new technique, described in the monthly journal, ACS Chemical Biology, represents a new use for an engineered form of green fluorescent protein, the topic of the 2008 Nobel Prize in Chemistry that is one of the most important research tools in biosciences.
In a development that could pave the way for treatment for rare neurological diseases and clues to more common ones, physician-scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have secured a grant to establish a clinical site for the Network for Excellence in Neuroscience Clinical Trials.
Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, and collaborators Drs. Martin Kolb and Kjetil Ask at McMaster University announced today additional measured advantages of inhaled GP-101 (aerosol pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF).
The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast. New research has found that while TFF3 protein expression is higher in well-differentiated low grade tumors and therefore associated with features of a good prognosis, it has a more sinister role in breast cancer invasion and metastasis.
› Verified 6 days ago